Paclitaxel Interactions
There are 530 drugs known to interact with paclitaxel, along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 60 are major, 452 are moderate, and 18 are minor.
- View all 530 medications that may interact with paclitaxel
- View paclitaxel alcohol/food interactions (1)
- View paclitaxel disease interactions (6)
Most frequently checked interactions
View interaction reports for paclitaxel and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Adriamycin (doxorubicin)
- Advil (ibuprofen)
- Aloxi (palonosetron)
- Aspirin Low Strength (aspirin)
- Avastin (bevacizumab)
- Benadryl (diphenhydramine)
- Claritin (loratadine)
- Compazine (prochlorperazine)
- CoQ10 (ubiquinone)
- Cytoxan (cyclophosphamide)
- Eliquis (apixaban)
- Emend (aprepitant)
- Fentanyl Transdermal System (fentanyl)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Herceptin (trastuzumab)
- Keytruda (pembrolizumab)
- MiraLAX (polyethylene glycol 3350)
- Neulasta (pegfilgrastim)
- Paracetamol (acetaminophen)
- Pepcid (famotidine)
- ProAir HFA (albuterol)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Quercetin (bioflavonoids)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Zofran (ondansetron)
Paclitaxel alcohol/food interactions
There is 1 alcohol/food interaction with paclitaxel.
Paclitaxel disease interactions
There are 6 disease interactions with paclitaxel which include:
- infections
- conduction disorders
- hepatic dysfunction
- myelosuppression
- peripheral neuropathy
- anaphylaxis
Report options
More about paclitaxel
- paclitaxel consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: mitotic inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Loqtorzi
Loqtorzi (toripalimab-tpzi) is a PD-1 inhibitor medicine used for the treatment of advanced ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.